1-4 of 4
Kira Kurbatova
Close
Sort by
Journal Articles

Quality of Life (QoL) and Clinical Outcomes of Dasatinib Treatment in TKI-Naive and Early Switched from Imatinib Patients with Chronic Myeloid Leukemia in Chronic Phase (CP CML) in a Real World Setting

Tatyana Ionova, PhD, Natalia Bulieva, MD, Olga Vinogradova, MD PhD, Kira Kurbatova, Elza Lomaia, MD PhD, Tatyana Nikitina, MD PhD, Natalia Novitskaya, Anna Rodionova, MD PhD, Elena Usacheva, Marina Chukavina, Marina Shumkova
Journal: Blood
Blood (2016) 128 (22): 5456.
https://doi.org/10.1182/blood.V128.22.5456.5456
Published: 2016
Journal Articles

Patient-Reported Outcomes in Myelofibrosis Patients Help to Identify Patients' Needs

Tatyana Ionova, PhD, Tatyana Nikitina, MD PhD, Elza Lomaia, MD PhD, Alexandr Myasnikov, MD PhD, Tatyana Pospelova, MD PhD, Andrey Evseev, MD PhD, Taras Gritsenko, MD PhD, Anna Lyamkina, MD PhD, Elena Machulaytene, MD PhD, Elena Usacheva, MD PhD, Anna Rodionova, MD PhD, Kira Kurbatova
Journal: Blood
Blood (2015) 126 (23): 5198.
https://doi.org/10.1182/blood.V126.23.5198.5198
Published: 2015
Journal Articles

Outcomes of Second-Line Treatment By Dasatinib in Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia Patients with and without Comorbidities

Tatyana Ionova, PhD, Tatyana Nikitina, MD PhD, Galina Kuchma, MD PhD, Elza Lomaia, MD PhD, Tatyana Shnaider, MD PhD, Elena Usacheva, MD PhD, Kira Kurbatova
Journal: Blood
Blood (2015) 126 (23): 5147.
https://doi.org/10.1182/blood.V126.23.5147.5147
Published: 2015
Journal Articles

Reduced Intensity Conditioning Regimens in Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis patients.

Andrei A. Novik, MD, FRCP, Alexey N. Kuznetsov, Vladimir Y Melnichenko, Denis A Fedorenko, Andrey Kartashov, Ruslana V Kruglina, Tatiana I Ionova, Kira Kurbatova, Gary J Gorodokin
Journal: Blood
Blood (2009) 114 (22): 2317.
https://doi.org/10.1182/blood.V114.22.2317.2317
Published: 2009